Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
about
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidationGlucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.Metabolism-based drug interactions involving oral azole antifungals in humans.Evaluation of metabolism-mediated herb-drug interactions.Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus.Strategies for control of zidovudine concentrations in serumPharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patientsS-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.New treatments for vulvovaginal candidiasisInteractions between antifungal and antiretroviral agents.Substrate inhibition kinetics in drug metabolism reactions.The role of drug metabolizing enzymes in clearance.Update on drug interactions with azole antifungal agents.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.Zidovudine azido-reductase in human liver microsomes: activation by ethacrynic acid, dipyridamole, and indomethacin and inhibition by human immunodeficiency virus protease inhibitors.Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms.Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
P2860
Q31034463-70813683-5B9E-43B0-AF29-E0DC50C2A073Q33693946-A1274CA5-892A-4610-A5C1-F1F133F6245AQ33719828-3AD61DDF-6910-4EED-8C7E-D50B74F1BD8DQ34238039-5F9B32D7-40BB-412B-AC91-33475991F285Q35114198-EFCA2715-CBC6-4CED-A47D-5C0EBF678AB2Q35121042-197C9782-B986-4349-9CFC-FFE73DBED1D5Q35138941-5AC16183-F9E1-4116-BE6B-1AA5009C4D85Q35826926-ADC4A150-F3DD-4F05-A042-AD0C01A56922Q36625081-8BA64B1F-9009-41B1-B8E9-B6CE56DAF9D6Q37719545-4C269761-7C19-4818-933E-0237A7635A0FQ37941118-13E21D31-E81C-4AEA-B022-299724264A3DQ38176051-3B5CC048-3FE9-4588-A08D-23C16C0EBD21Q38549824-EFC25ACE-4C67-4E9B-9FB7-73D627523DC1Q38696236-FAA335EC-D6EF-40EF-8028-B49CDC37EBE6Q39051706-4311326C-884A-40A4-A098-B2A8FF6AA694Q39557951-C4D89349-4DBF-48F3-9F73-D89E3ECDE73AQ40051462-9B9E5AFF-14A5-4DBC-938A-599B581320FDQ42132550-A57B1FF5-B327-4DD2-9790-FAD3BFE26288Q42912104-C992E618-6CAE-4C70-B5DA-C72A1FF138A5Q43452825-D3AEF174-22D2-4794-BA9E-09AD4D068C76Q52937304-6B1B5003-07C7-4065-ADB7-BEE421AF2FB4
P2860
Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@en
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@nl
type
label
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@en
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@nl
prefLabel
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@en
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@nl
P2093
P356
P1476
Effect of fluconazole on zidov ...... human immunodeficiency virus.
@en
P2093
P304
P356
10.1093/INFDIS/169.5.1103
P407
P577
1994-05-01T00:00:00Z